Weis Shirley A 4

What Happened
Shirley A. Weis, a director of Pediatrix Medical Group, received an award of 7,196 restricted common shares on 2026-05-07. The filing lists an acquisition price of $0.00 (total reported value $0), reflecting a grant under the issuer's equity plan rather than an open‑market purchase or sale. Per the filing, these shares will vest on May 7, 2027.

Key Details

• Transaction date: 2026-05-07; Transaction type: Award/Grant (code A); Shares: 7,196; Price per share reported: $0.00.
• Vesting: Shares vest on May 7, 2027 (footnote F1).
• Ownership after transaction: Not specified in the filing.
• Beneficial ownership: The reporting person and her husband are trustees of the trust that holds these securities; immediate family members are beneficiaries (footnote F2).
• Filing timeliness: Form 4 filed 2026-05-11 for a 2026-05-07 transaction — this is after the typical 2-business-day Form 4 deadline (i.e., the filing appears late).
• Exhibit/Remarks: See Exhibit 24.1 (Power of Attorney).

Context
This was a restricted stock award as part of the company's incentive compensation plan, not an open‑market purchase. Restricted awards are common director compensation and are subject to vesting conditions; they do not necessarily reflect immediate buying or selling intent. The shares are held in a trust controlled by the reporting person and her spouse, with family beneficiaries.